DEA to hold hearing on rescheduling marijuana to Schedule III on December 2, focusing on logistics, not testimonies.
The DEA will hold hearings on whether to lessen restrictions on marijuana where it would be in the same class of drugs as ...
By Terry Hacienda, The Fresh Toast It has been clear the DEA It has been clear Anne Milgram, the head of the D ...
A DEA administrative law judge has denied MedPharm's motion to participate in the December 2 marijuana rescheduling ...
Nobody knows how a Schedule III designation will change cannabis policy across the board, but the Department of Veterans ...
The motion, which asks the DOJ to take over moving cannabis down the list, argues the DEA has "stacked the deck" against ...
The cannabis industry is concerned about the direction of regulations – and the DEA is still against the plant.